Medical News

RSS

Reduced insulin sensitivity linked to smaller brain size, deteriorated language skills in seniors

New research from Uppsala University shows that reduced insulin sensitivity is linked to smaller brain size and deteriorated language skills in seniors. The findings are now published in the scientific journal Diabetes Care.

2 Feb 2012

FDA EMDAC to discuss Arena's lorcaserin NDA resubmission in second quarter

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified Arena that an Endocrinologic and Metabolic Drugs Advisory Committee meeting to discuss the lorcaserin New Drug Application (NDA) resubmission will be held in the second quarter of 2012. Confirmation and details of the meeting will be published in the Federal Register.

2 Feb 2012

Cancer Genomics now available online

Genome Research publishes online and in print today a special issue entitled, "Cancer Genomics," highlighting insights gained form cutting-edge genomic and epigenomic analyses of cancer.

2 Feb 2012

Almac introduces NGS data analysis services

Almac's Diagnostics business unit today announced launch of its advanced Next Generation Sequencing (NGS) data analysis services.

2 Feb 2012

Clear link between male subfertility and lower risk of prostate cancer

Involuntary childlessness owing to reduced fertility is a concern for many men. However, these men do have one advantage - they run a significantly lower risk of suffering from prostate cancer. Researchers are interested in whether this phenomenon could be used in the fight against cancer.

2 Feb 2012

AstraZeneca, Impax enter license agreement to commercialize Zomig in the U.S.

Impax Pharmaceuticals, the branded products business unit of Impax Laboratories, Inc., announced today that it has licensed from AstraZeneca the exclusive United States (U.S.) commercial rights to Zomig (zolmitriptan) tablet, orally disintegrating tablet, and nasal spray formulations.

2 Feb 2012

Medical Properties Trust prices 20.5M public offering of common stock

Medical Properties Trust, Inc. announced today that it priced its underwritten public offering of 20,500,000 shares of common stock at $9.75 per share.

2 Feb 2012

Annual Depression on College Campuses Conference to be held March 7-8

How can college students draw upon their own strengths, resilience, and sense of social connectedness to help them maintain mental health and wellness? Researchers, students and U-M community members will discuss this question at the annual Depression on College Campuses Conference, held March 7-8. The conference - which is marking its 10th anniversary - features workshops and sessions focused on reframing the discussion about mental health on college campuses by emphasizing the importance of student strengths in preventing depression.

2 Feb 2012

Tips to avoid infections during Valentine's Day

Say "I love you" with flowers, chocolates or a greeting card, but be careful when you kiss this Valentine's Day. "Mid-February is usually the peak season for infectious diseases, such as the seasonal and H1N1 flu, mononucleosis, colds and coughs," says Jorge Parada, MD, medical director, infectious disease at Loyola University Health System. "And don't rely on obvious signs of illness - such as sneezing or fever as a tip off. People with infectious diseases start shedding the virus before they experience the full effect of the illness."

2 Feb 2012

USF receives DOD grant for battlefield-related TBI research

The University of South Florida (USF) has received a $1.57 million U.S. Department of Defense grant to conduct translational research on traumatic brain injury and other battlefield related injuries and diseases.

2 Feb 2012

People with sleep apnea may have increased risk of brain lesions, silent strokes

People with severe sleep apnea may have an increased risk of silent strokes and small lesions in the brain, according to a small study presented at the American Stroke Association's International Stroke Conference 2012.

2 Feb 2012

Ligand announces results from melphalan Phase II study on multiple myeloma

Ligand Pharmaceuticals Incorporated announced that results from the Phase II study of its Captisol-enabled, propylene glycol-free (PG-free) Melphalan program were featured this evening in a poster presentation at the combined annual meetings of the Center for International Blood & Marrow Transplant Research (CIBMTR) and the American Society for Blood and Marrow Transplantation (ASBMT) in San Diego.

2 Feb 2012

Study finds wide variation in rates of diabetes across developing countries

Rates of diabetes vary widely across developing countries worldwide, according to a new analysis led by Dr. Longjian Liu of Drexel University's School of Public Health.

2 Feb 2012

WSU research project to promote HIV testing in African-Americans

A grant from the Centers for Disease Control and Prevention, administered by the Michigan Department of Community Health, is helping a Wayne State University researcher's effort to promote HIV testing among African-Americans.

2 Feb 2012

Romney claims Florida primary win

Rick Santorum, another GOP presidential hopeful, says the messy Florida campaign caused damage to Republicans and also plans to deliver a speech about "Obamacare" and "Romneycare" today in Colorado. The Democratic National Committee hits Mitt Romney on Medicare, and Rep. Pete Stark, D-Calif., offers legislation aimed at Newt Gingrich.

2 Feb 2012

Genentech receives FDA approval for Vismodegib to treat skin cancer

A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the U.S. Food and Drug Administration, a remarkable accomplishment in new drug development.

2 Feb 2012

FDA extends Novartis' Gleevec label to three-year treatment in patients with KIT+ GIST after surgery

Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial.

1 Feb 2012

Brief 10-minute massage helps reduce inflammation in muscle

Researchers at McMaster University have discovered a brief 10-minute massage helps reduce inflammation in muscle.

1 Feb 2012

Effort to address void in worldwide medical education

Dr. Rebekah Gee, Assistant Professor at LSU Health Sciences Center New Orleans Schools of Public Health and Medicine, is the lead author of an article published in the January 28, 2012 issue of The Lancet regarding the initial effort to address a void in medical education worldwide - leadership.

1 Feb 2012

Clazosentan reduces risk of blood vessel spasm in patients with brain aneurysm

An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association's International Stroke Conference 2012.

1 Feb 2012